PHEOCHROMOCYTOMA/PARAGANGLIOMA
Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a daily pill tame rare cancers in teens? new trial investigates
Disease control Not yet recruitingThis phase 2 trial tests the safety of belzutifan, a daily oral tablet, in adolescents with rare solid tumors that cannot be surgically removed or have spread. The study includes three tumor types: pheochromocytoma/paraganglioma (PPGL), wild-type gastrointestinal stromal tumors (…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New imaging agent could improve detection of rare cancers
Diagnosis Not yet recruitingThis study will compare a new radioactive tracer, 18F-AmBF3TATE, to the standard tracer 68Ga-DOTATATE for PET scans in people with neuroendocrine tumors. The goal is to see if the new tracer is as good or better at finding tumors. About 51 participants will receive both tracers a…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC